Bluechiip participating in Advanced Therapies Week (ATW) 2024 

Bluechiip kicks off the New Year by exhibiting at the Advanced Therapies Week (ATW) in Miami on January 16^th-19th, hosted by Phacilitate. The event brings together the world’s leading experts to share insights, inspire ideas and build new partnerships than can make a real difference.  . This year, Bluechiip is excited to be exhibiting in the Innovation Zone, which provides a unique environment for showcasing the latest in technology and innovation to help support this quickly evolving industry. 

Bluechiip is pleased to also announce that as part of ATW, ARMI | BioFabUSA, will be presenting a brief presentation on their ongoing collaboration with Bluechiip. ARMI | BioFabUSA’s Chief Operating Officer, Ned Gordon, will present a real-world example of how Bluechiip's Advanced Sample Management solution is being utilized in their state-of-the-art manufacturing facility. A pioneer in the field, Ned and his team are propelling the US to global leadership in biomanufacturing, by providing: competitive, capable, innovative ecosystem for cell, tissue, and organ manufacturing. 

We look forward to welcoming you ATW 2024. Visit us in the Innovation Zone, location P7. 

Contact a Bluechiip team member today at [email protected]  

About Bluechiip

Bluechiip (ASX:BCT), a leader in the development of advanced sample management solutions, understands that every biological sample is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip provides a range of products and services across clinical research, drug development and advanced cell therapies to support the world’s leading laboratories across pharmaceutical, biotech and academic institutes globally.

Bluechiip’s Advanced Sample Management Solution is the only commercially available solution that provides sample temperature with ID, even in harsh cryogenic environments; driving productivity and improving quality to ultimately deliver confidence in every sample.